Please provide your email address to receive an email when new articles are posted on . Researchers have proposed a machine-learning algorithm for personalized treatment selection in patients with ...
A research team led by Prof. Sun Cheng from the University of Science and Technology of China (USTC), in collaboration with researchers from the Agency for Science, Technology and Research and Chinese ...
A research team led by Prof. SUN Cheng from the University of Science and Technology of China (USTC) of the Chinese Academy of Sciences, along with collaborators from the Agency for Science, ...
Molecular profile of hepatocellular carcinoma (HCC) in older (OA) versus younger adults (YA) receiving tyrosine kinase inhibitors: Does age matter? This is an ASCO Meeting Abstract from the 2025 ASCO ...
This retrospective analysis examined real-world data from ctDNA testing on 125 patients with HCC (721 plasma samples) undergoing curative-intent treatments and SOC management. Patients were divided ...
Artificial intelligence (AI) models have potential to help clinicians assess risk in patients with hepatocellular carcinoma (HCC) to inform disease management, a new study found. In HCC that is not ...
The research on important prognostic factors after LT has shown that, in addition to the size and number of tumors, the presence of vascular invasion and grade of histological differentiation are ...
Adjuvant therapy with atezolizumab (Tecentriq) and bevacizumab (Avastin) increased recurrence-free survival of patients with hepatocellular carcinoma (HCC) following surgical resection or ablation, ...
Hepatocellular carcinoma (HCC), a leading cause of cancer-related mortality globally, exhibits a dismal five-year survival rate of only 18%. Major contributing factors to HCC include viral hepatitis ...
The initial results of the IMbrave050 trial raised hopes that an effective adjuvant regimen for hepatocellular carcinoma (HCC) might finally have arrived. Patients with HCC treated with a combination ...
A risk stratification algorithm may be able to predict which patients with advanced chronic liver disease are at risk of developing hepatocellular carcinoma (HCC), according to a large-scale ...
Adjuvant therapy for hepatocellular carcinoma after curative treatment: Several unanswered questions
Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies globally and is the third leading cause of cancer-related deaths. The primary curative treatments for HCC are liver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results